Sort
23,748 grants matching “melanoma”
ANALYSIS OF CD8 T CELL RESPONSES TO TUMORS
$272,475Trudeau Institute, Inc. · R01 · FY2003 · CA
Repression by C SKI and Melanoma Progression
$272,470Estela E Medrano · Baylor College Of Medicine · R01 · FY2006 · CA
MDA-7/IL-24: Therapy of Prostate Cancer
$272,456Columbia University Health Sciences · P01 · FY2005 · CA
Analysis of the Signaling and Mechanical Cues Promoting Invasion in Melanoma
$272,428Andre Levchenko · Yale University · U01 · FY2014 · CA
DCs Regulate Chemokine Responsiveness of Melanoma-Specific T Cells
$272,347Pawel Kalinski · University Of Pittsburgh At Pittsburgh · P50 · FY2012 · CA
PTPases as Therapeutic Targets
$272,340Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2004 · CA
PTPases as Therapeutic Targets
$272,340Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2003 · CA
PTPases as Therapeutic Targets
$272,340Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2005 · CA
RETINOIC ACID RECEPTOR GAMMA SPECIFIC SIGNALING IN MELAN
$272,319Boston University Medical Campus · R01 · FY2001 · CA
Regulatory Network Differences/Diverse Tumor Subtypes/Design Combinatorial Therap
$272,306Chris Sander · Sloan-Kettering Inst Can Research · U54 · FY2010 · CA
Innate Factors in Tumor Antigen Cross-Presentation
$272,268Thomas F Gajewski · University Of Chicago · P01 · FY2009 · CA
HOST/TUMOR INTERACTIONS IN IMMUNOTHERAPY OF PROSTATE CA
$272,244University Of Iowa · R01 · FY2003 · CA
HOST/TUMOR INTERACTIONS IN IMMUNOTHERAPY OF PROSTATE CA
$272,244University Of Iowa · R01 · FY2002 · CA
HOST/TUMOR INTERACTIONS IN IMMUNOTHERAPY OF PROSTATE CA
$272,244University Of Iowa · R01 · FY2004 · CA
HOST/TUMOR INTERACTIONS IN IMMUNOTHERAPY OF PROSTATE CA
$272,244University Of Iowa · R01 · FY2005 · CA
HOST/TUMOR INTERACTIONS IN IMMUNOTHERAPY OF PROSTATE CA
$272,244University Of Iowa · R01 · FY2001 · CA
NOVEL APPROACAHES FOR IMPROVING PEDIATRIC BRAFV600E GLIOMA PATIENT OUTCOMES
$272,244Charles David James · University Of California, San Francisco · P50 · FY2017 · CA
TGFbeta IN THE BONE MICROENVIRONMENT: ROLE IN TUMOR METASTASIS
$272,224Theresa A Guise · Indiana University Indianapolis · R01 · FY2012 · CA
TGFbeta IN THE BONE MICROENVIRONMENT: ROLE IN TUMOR METASTASIS
$272,224Theresa A Guise · Indiana University Indianapolis · R01 · FY2011 · CA
Exploiting Chromatin Alteration to Treat Clear Cell Carcinoma
$272,150William G Kaelin · Beth Israel Deaconess Medical Center · P50 · FY2019 · CA
Rapid, low-cost mRNA analysis system for cancer companion diagnostics
$272,105Philip Measor · Liquilume Diagnostics, Inc. · R43 · FY2012 · TR
Novel anti-melanoma agents and their mechanism of action
$271,958Emory University · R01 · FY2005 · CA
Augmenting the Immunogenicity of Melanoma Through Manipulation of Histone Deacet
$271,916Eduardo M Sotomayor · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2016 · CA
ABCB5 and Melanoma Stem Cells: Implications for Prognosis & Therapeutic Targeting
$271,866Frank Markus · Brigham And Women'S Hospital · P50 · FY2009 · CA
OVERCOMING TUMOR EVASION MECHANISMS IN HODGKIN DISEASE
$271,819Cliona M Rooney · Baylor College Of Medicine · P01 · FY2011 · CA